Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology

NCT04389541 is registered in ClinicalTrials.gov with iOMEDICO AG as lead sponsor.

NCT NCT04389541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04389541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology
Lead sponsor
iOMEDICO AG
Phase
Observational
Overall status
Completed
Start date
April 17, 2020
Completion date
June 30, 2023
Enrollment
499 (actual)
Sites
97

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors or hematologic malignancies